Manulife (Manufacturers Life Insurance)’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$995K Sell
71,672
-1,448
-2% -$23.1K ﹤0.01% 1833
2025
Q4
$1.19M Sell
73,120
-4,288
-6% -$70K ﹤0.01% 1764
2025
Q3
$1.16M Buy
77,408
+674
+0.9% +$8.21K ﹤0.01% 1782
2025
Q2
$894K Buy
76,734
+12,299
+19% +$112K ﹤0.01% 1875
2025
Q1
$479K Buy
64,435
+20,473
+47% +$157K ﹤0.01% 2167
2024
Q4
$264K Sell
43,962
-3,321
-7% -$18.3K ﹤0.01% 2509
2024
Q3
$242K Sell
47,283
-1,551
-3% -$6.76K ﹤0.01% 2578
2024
Q2
$177K Buy
48,834
+2,710
+6% +$8.6K ﹤0.01% 2651
2024
Q1
$148K Sell
46,124
-16,680
-27% -$64.5K ﹤0.01% 2685
2023
Q4
$308K Sell
62,804
-283
-0.4% -$1.29K ﹤0.01% 2398
2023
Q3
$344K Sell
63,087
-42,527
-40% -$281K ﹤0.01% 2308
2023
Q2
$709K Sell
105,614
-14,417
-12% -$107K ﹤0.01% 1837
2023
Q1
$1.06M Buy
120,031
+227
+0.2% +$2K ﹤0.01% 1610
2022
Q4
$910K Buy
119,804
+791
+0.7% +$6.15K ﹤0.01% 1657
2022
Q3
$828K Sell
119,013
-782
-0.7% -$7.36K ﹤0.01% 1690
2022
Q2
$979K Buy
119,795
+63,171
+112% +$555K ﹤0.01% 1661
2022
Q1
$785K Buy
+56,624
New +$890K ﹤0.01% 1896

Other funds holding ADPT

Manulife (Manufacturers Life Insurance)'s ADPT Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Adaptive Biotechnologies (ADPT) stake by 2% in Q1 2026, selling an estimated $23.1K and leaving 71,672 shares worth $995K. The position accounts for ﹤0.01% of the portfolio, ranked #1833.

Manulife (Manufacturers Life Insurance) first reported a position in ADPT in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.19M in Q4 2025. 296 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 71,672 shares of Adaptive Biotechnologies worth $995K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 1,448 Adaptive Biotechnologies shares in Q1 2026, an estimated $23.1K.
  • Adaptive Biotechnologies made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1833 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Adaptive Biotechnologies in Q1 2022 and has held it in 17 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Adaptive Biotechnologies position peaked at $1.19M in Q4 2025.
  • 296 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.